Compare · ALPA vs RMD
ALPA vs RMD
Side-by-side comparison of Alpha Healthcare Acquisition Corp. III (ALPA) and ResMed Inc. (RMD): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both ALPA and RMD operate in Medical/Dental Instruments (Health Care), so they compete in similar markets.
- RMD carries a market cap of $33.60B.
- RMD has hit the wire 10 times in the past 4 weeks while ALPA has been quiet.
- RMD has more recent analyst coverage (25 ratings vs 0 for ALPA).
- Company
- Alpha Healthcare Acquisition Corp. III
- ResMed Inc.
- Price
- -
- $240.05+0.38%
- Market cap
- -
- $33.60B
- 1M return
- -
- +1.61%
- 1Y return
- -
- -5.18%
- Industry
- Medical/Dental Instruments
- Medical/Dental Instruments
- Exchange
- NASDAQ
- NYSE
- IPO
- 2021
- News (4w)
- 0
- 10
- Recent ratings
- 0
- 25
Alpha Healthcare Acquisition Corp. III
Alpha Healthcare Acquisition Corp. III focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or other business combination with one or more businesses or entities. The company was incorporated in 2021 and is based in New York, New York.
ResMed Inc.
ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications that diagnose, treat, and manage respiratory disorders comprising sleep apnea, chronic obstructive pulmonary disease, neuromuscular disease, and other chronic diseases. The company operates in two segments, Sleep and Respiratory Care, and Software as a Service. It offers various products and solutions for a range of respiratory disorders, including technologies to be applied in medical and consumer products, ventilation devices, diagnostic products, mask systems for use in the hospital and home, headgear and other accessories, dental devices, portable oxygen concentrators, and cloud-based software informatics solutions to manage patient outcomes, as well as provides customer and business processes. The company also provides U-Sleep, which enables automated patient coaching through a text, email, or interactive voice phone call; AirView that enables remote monitoring, over-the-air trouble shooting, and changing of device settings; and myAir, a patient engagement application that offers sleep data and a daily score based on their previous night's data, as well as connectivity module and propeller solutions. In addition, it provides business management software and services to out-of-hospital providers, home medical equipment, pharmacy, home infusion, orthotics, and prosthetics; and HEALTHCAREfirst and MatrixCare solutions. The company markets its products to sleep clinics, home healthcare dealers, patients, hospitals, physicians, and third-party payers through a network of distributors and direct sales force in approximately 140 countries. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California.
Latest ALPA
- SEC Form SC 13G/A filed by Alpha Healthcare Acquisition Corp. III (Amendment)
- SEC Form SC 13G/A filed by Alpha Healthcare Acquisition Corp. III (Amendment)
- SEC Form SC 13G filed by Alpha Healthcare Acquisition Corp. III
- SEC Form SC 13G/A filed by Alpha Healthcare Acquisition Corp. III (Amendment)
- SEC Form SC 13G/A filed by Alpha Healthcare Acquisition Corp. III (Amendment)
- SEC Form SC 13G/A filed by Alpha Healthcare Acquisition Corp. III (Amendment)
- SEC Form SC 13G/A filed by Alpha Healthcare Acquisition Corp. III (Amendment)
- SEC Form SC 13G filed by Alpha Healthcare Acquisition Corp. III
- SEC Form SC 13G/A filed by Alpha Healthcare Acquisition Corp. III (Amendment)
- Alpha Healthcare Acquisition Corp. III filed SEC Form 8-K: Other Events, Financial Statements and Exhibits
Latest RMD
- Director De Witte Jan covered exercise/tax liability with 60 units of ResMed Common Stock, decreasing direct ownership by 1% to 4,201 units (SEC Form 4) (for tax liability)
- Director Gill Harjit covered exercise/tax liability with 36 units of ResMed Common Stock, decreasing direct ownership by 0.33% to 10,904 units (SEC Form 4) (withholding tax)
- Global General Counsel Rider Michael J covered exercise/tax liability with 1,944 units of ResMed Common Stock, decreasing direct ownership by 16% to 10,417 units (SEC Form 4) (withholding obligation)
- Chairman and CEO Farrell Michael J. exercised 4,993 units of ResMed Common Stock at a strike of $146.34 and sold $1,175,089 worth of ResMed Common Stock (4,993 units at $235.35) as part of a pre-agreed trading plan (SEC Form 4)
- ResMed downgraded by Canaccord Genuity
- SEC Form 10-Q filed by ResMed Inc.
- SEC Form 8-K filed by ResMed Inc.
- Resmed Inc. Announces Results for the First Quarter of Fiscal Year 2027
- Global General Counsel Rider Michael J sold $102,000 worth of ResMed Common Stock (400 units at $255.00) as part of a pre-agreed trading plan (SEC Form 4)
- Resmed Launches AirTouch™ F40 Full Face Fabric CPAP Mask in the U.S.